Organon & Co. reported GAAP net income of $164 million for the quarter ended September 30, 2026, up from $160 million in 2025, while adjusted net income fell to $256 million from $263 million and adjusted EBITDA declined to $502 million from $518 million.
OGN · Organon & Co. · Documents
$13.90
+0.00 (+0.00%)
At close · Nov 17
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Market Cap
$3.65B
Shares
262.62M
Volume · Nov 17
4.16M
Avg daily vol (3M)
2.71M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Oct 30
Current report
8-K
GAAP net income rose as adjusted earnings declined
Oct 30
Quarterly report
10-Q
FY2026 Q3, ended Sep 30
Sun Pharma acquisition priced at $14.00 per share
Organon agreed to sell all outstanding shares to Sun Pharma for $14.00 per share in cash, with closing expected by early 2027. Worldwide sales were $1.6 billion for the three months ended September 30, 2026, down 2%.
Revenue $1.57B
▼ 1.7%
Net income $164M
▲ 2.5%
Diluted EPS $0.60
▼ 1.6%
Jul 31
Jul 31
Quarterly report
10-Q
FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $1.56B
▼ 2.3%
Net income $108M
▼ 25.5%
Diluted EPS $0.40
▼ 28.6%
Jul 23
Jul 17
Jul 17
Jun 17
Jun 11
Current report
8-K
Events of Jun 9
Director or officer change, or executive pay, Shareholder vote results
AI summary on its way
Jun 11
Jun 9
Jun 1
May 4
Quarterly report
10-Q
FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1
AI summary on its way
Revenue $1.46B
▼ 3.5%
Net income $146M
▲ 67.8%
Diluted EPS $0.55
▲ 66.7%
Apr 30
Apr 30
Apr 30
Apr 27
Apr 27
Apr 27
Apr 27
Current report
8-K
Events of Apr 26
Entered into a material agreement, Director or officer change, or executive pay, Regulation FD disclosure
AI summary on its way
Apr 27
Apr 24
Apr 24
Apr 24
Feb 24
Annual report
10-K
FY2025, ended Dec 31
Annual report for FY2025
AI summary on its way
Revenue $6.22B
▼ 2.9%
Net income $187M
▼ 78.4%
Diluted EPS $0.72
▼ 78.4%
Feb 20
Feb 12
Feb 12
2025
Nov 10
Earnings call
Q3 2025 earnings call
Nov 10
Quarterly report
10-Q/A
Ended Mar 31
Quarterly report for the period ended Mar 31, 2025
Nov 10
Quarterly report
10-Q/A
Ended Jun 30
Quarterly report for the period ended Jun 30, 2025
Nov 10
Annual report
10-K/A
FY2024, ended Dec 31
Annual report for FY2024
Revenue $6.4B
▲ 2.2%
Net income $864M
▼ 15.5%
Diluted EPS $3.33
▼ 16.5%
Nov 10
Current report
8-K
Financial results, Regulation FD disclosure
Nov 10
Quarterly report
10-Q
FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $1.6B
▲ 1.3%
Net income $160M
▼ 55.4%
Diluted EPS $0.61
▼ 55.8%
Nov 7
Current report
8-K
Events of Nov 3
Director or officer change, or executive pay
Oct 30
Current report
8-K/A
Events of Oct 26
Director or officer change, or executive pay
Oct 27
Current report
8-K
Events of Oct 26
Director or officer change, or executive pay, Other events
Aug 6
Quarterly report
10-Q
FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $1.59B
▼ 0.8%
Net income $145M
▼ 25.6%
Diluted EPS $0.56
▼ 25.3%
Aug 5
Earnings call
Q2 2025 earnings call
Aug 5
Current report
8-K
Financial results, Regulation FD disclosure
Jun 12
Current report
8-K
Events of Jun 10
Director or officer change, or executive pay, Shareholder vote results
May 27
Current report
8-K
Other events
May 2
Quarterly report
10-Q
FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $1.51B
▼ 6.7%
Net income $87M
▼ 56.7%
Diluted EPS $0.33
▼ 57.7%
May 1
Earnings call
Q1 2025 earnings call
May 1
Current report
8-K
Financial results, Regulation FD disclosure, Other events
Apr 25
Proxy statement
DEF 14A
Meeting Jun 10, 2025
Proxy statement
Apr 25
Annual report to holders
ARS
Annual report to holders
Apr 25
Proxy statement
DEFA14A
Proxy statement
Apr 15
Current report
8-K
Director or officer change, or executive pay, Regulation FD disclosure
Feb 28
Annual report
10-K
FY2024, ended Dec 31
Annual report for FY2024
Revenue $6.4B
▲ 2.2%
Net income $864M
▼ 15.5%
Diluted EPS $3.33
▼ 16.5%
Showing 1–50 of 119 documents
Key facts
CIK
1821825
CUSIP
68622V106
13F (30d)
642 filings
554 filers
Visit website
Investor relations